Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination

INTRODUCTION: The leading professional organizations in the field of hematology have recommended severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) vaccination for all patients with hematologic malignancies notwithstanding efficacy concerns. Here we report a systematic literature review re...

Descripción completa

Detalles Bibliográficos
Autores principales: Guven, Deniz C, Sahin, Taha K, Akın, Serkan, Uckun, Fatih M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982368/
https://www.ncbi.nlm.nih.gov/pubmed/35274729
http://dx.doi.org/10.1093/oncolo/oyac032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982368/
https://www.ncbi.nlm.nih.gov/pubmed/35274729
http://dx.doi.org/10.1093/oncolo/oyac032

Ejemplares similares